Page last updated: 2024-11-04

sulfasalazine and Communicable Diseases

sulfasalazine has been researched along with Communicable Diseases in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Communicable Diseases: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Le Roux-Villet, C1
Prost-Squarcioni, C1
Alexandre, M1
Caux, F1
Pascal, F1
Doan, S1
Brette, MD1
Soued, I1
Gabison, É1
Aucouturier, F1
Letestu, R1
Laroche, L1
Bachelez, H1

Other Studies

1 other study available for sulfasalazine and Communicable Diseases

ArticleYear
Rituximab for patients with refractory mucous membrane pemphigoid.
    Archives of dermatology, 2011, Volume: 147, Issue:7

    Topics: Adolescent; Adult; Agammaglobulinemia; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Deriv

2011